Cargando…
Dyslipidemia in Patients with Chronic Kidney Disease: An Updated Overview
Dyslipidemia is a potentially modifiable cardiovascular risk factor. Whereas the recommendations for the treatment target of dyslipidemia in the general population are being more and more rigorous, the 2013 Kidney Disease: Improving Global Outcomes clinical practice guideline for lipid management in...
Autores principales: | Suh, Sang Heon, Kim, Soo Wan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Diabetes Association
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555535/ https://www.ncbi.nlm.nih.gov/pubmed/37482655 http://dx.doi.org/10.4093/dmj.2023.0067 |
Ejemplares similares
-
Dyslipidemia in patients with chronic kidney disease: etiology and management
por: Mikolasevic, Ivana, et al.
Publicado: (2017) -
Dietary Lipids and Dyslipidemia in Chronic Kidney Disease
por: Kochan, Zdzislaw, et al.
Publicado: (2021) -
COVID–19 and chronic kidney disease: an updated overview of reviews
por: Jdiaa, Sara S., et al.
Publicado: (2022) -
Update on dyslipidemia in hypothyroidism: the mechanism of dyslipidemia in hypothyroidism
por: Liu, Huixing, et al.
Publicado: (2022) -
Angiotensin-converting enzyme 2 and kidney diseases in the era of coronavirus disease 2019
por: Suh, Sang Heon, et al.
Publicado: (2021)